IL1B and diabetic kidney disease: The mechanism of accelerated DKD damage is associated with the activation of the MyD88/NF-κB pathway by the binding of LPS to TLRs that contributes to increased production of pro-inflammatory factors, including tumor necrosis factor-α (TNF-α), interleukin-1(IL-1), and IL-6 (73).